BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7159753)

  • 1. The effect of cetiedil on red cell membrane permeability.
    Schmidt WF; Asakura T; Schwartz E
    Blood Cells; 1982; 8(2):289-98. PubMed ID: 7159753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cetiedil on cation and water movements in erythrocytes.
    Schmidt WF; Asakura T; Schwartz E
    J Clin Invest; 1982 Mar; 69(3):589-94. PubMed ID: 7061704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
    Berkowitz LR; Orringer EP
    J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetiedil-induced increase in water exchange in sickle cell anemia erythrocytes.
    Narasimhan C; Fung LW
    J Pharm Sci; 1991 Nov; 80(11):1101-2. PubMed ID: 1815064
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the mechanism by which cetiedil inhibits sickling.
    Abu-Salah KM; Gambo AH
    Life Sci; 2002 Jan; 70(9):1003-11. PubMed ID: 11860149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of erythrocyte calcium transport by cetiedil.
    Levine SN; Berkowitz LR; Orringer EP
    Pharmacology; 1988; 36(1):44-51. PubMed ID: 2829242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.
    Benton DC; Roxburgh CJ; Ganellin CR; Shiner MA; Jenkinson DH
    Br J Pharmacol; 1999 Jan; 126(1):169-78. PubMed ID: 10051133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
    Stuart J; Stone PC; Bilto YY; Keidan AJ
    J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological alterations of cation movements in red blood cells.
    Parker JC; Welt LG
    Arch Intern Med; 1972 Feb; 129(2):320-32. PubMed ID: 4258090
    [No Abstract]   [Full Text] [Related]  

  • 12. Antisickling effects of membrane-interacting compounds.
    Ohnishi ST
    Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of sickling.
    Mentzer WC
    Am J Pediatr Hematol Oncol; 1982; 4(3):320-7. PubMed ID: 7149171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the mechanism by which cetiedil inhibits the Gardos phenomenon.
    Berkowitz LR; Orringer EP
    Am J Hematol; 1984 Oct; 17(3):217-23. PubMed ID: 6475933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedil.
    Roxburgh CJ; Ganellin CR; Shiner MA; Benton DC; Dunn PM; Ayalew Y; Jenkinson DH
    J Pharm Pharmacol; 1996 Aug; 48(8):851-7. PubMed ID: 8887737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell membrane abnormalities in sickle cell anemia.
    Bookchin RM; Lew VL
    Prog Hematol; 1983; 13():1-23. PubMed ID: 6322226
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin-induced membrane depolarization of platelets and its inhibition by cetiedil.
    Yamaguchi A; Azuma H; Sekizaki S; Suzuki H; Tanoue K; Yamazaki H
    J Biochem; 1988 May; 103(5):787-91. PubMed ID: 3182748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of methyl acetimidate as an extracorporeal antisickling agent.
    Chao TL; Berenfeld MR; Gabuzda TG
    Am J Pediatr Hematol Oncol; 1984; 6(1):55-8. PubMed ID: 6711765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
    Ueno H; Yatco E; Benjamin LJ; Manning JM
    J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of the permeability defect in hereditary stomatocytosis by dimethyl adipimidate.
    Mentzer WC; Lubin BH; Emmons S
    N Engl J Med; 1976 May; 294(22):1200-4. PubMed ID: 1264135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.